The Indian pharmaceutical industry has proved to be the major player in the domestic and international market. This supremacy has been achieved through an enduring process of manufacturing, competitive prices practice, and highly skilled staff. One of the major strategies for Indian pharma sector in terms of growth is its global expansion which is the key driver of this industry's performance.

The degree to which Indian pharma progresses towards the international level depends crucially on its flexibility and robustness in the global health arena. This case study shows us the different strategies that the Indian pharmaceutical companies have been using to expand their global reach and the factors that have contributed to the expansion of the industry.

The Indian pharmaceutical industry has shown significant growth in recent years. Several factors that help to drive this growth are mentioned below:

Indian companies have transformed into key contributors in the global pharmaceutical market from primarily being domestic players. This has been achieved by pursuing strategic initiatives, adopting innovative approaches, and having the determination to deliver quality products. The Indian pharmaceutical companies have secured their place at the global level by leveraging technological advancements, establishing strategic partnerships, and steering their way through complex regulatory requirements. The Indian pharmaceutical industry’s trajectory has been on an uptrend due to its resilience and adaptability, which has paved the way through stringent regulations and intense competition. In order to capitalise on upcoming opportunities and overcome challenges, Indian companies need to adopt an approach of sustained investment in R&D, innovation, and strategic collaboration. The global impact of Indian pharmaceutical companies in the industry's ever-evolving landscape will not only boost economic growth but also contribute towards enhancing healthcare access and quality of life worldwide.

• Cost effectiveness: Compared to any developed economy, India has a key advantage of being cost-effective in terms of the manufacturing process and labour. This finally leads Indian pharma firms to cost efficiently produce high quality generic drugs, which in turn helps them to become attractive players in the international market.
• Skilled labour force: The Indian pharma industry leverages upon trained professionals namely scientists, researchers, and technicians to conduct effective studies and to achieve high quality standards along with innovation in drug discovery and development.
• Generic drug manufacturing: The Indian pharma industry is now on the road to dominating the generic medicine manufacturing worldwide. This has been achieved with the aid of reverse engineering the patented medicines and regulatory approvals. The manufacturing of generic drugs considerably benefits emerging nations.
• Research and development: Indian drug companies to develop new drugs are investing heavily on therapeutic potency and also improving upon the manufacturing process. By putting innovation first, companies have been able to enter the international market through complex generic drugs, biosimilars and niche formulations of drugs.
• Regulatory compliance: In order to maintain the highest quality standards, Indian pharmaceuticals follow the regulatory standards set by the international regulatory authorities such as the Food and Drug Administration (FDA), European Medicines Agency (EMA) and World Health Organization (WHO). This gives boost to Indian pharmaceutical companies worldwide.
• Collaborations and strategic partnerships: In order to widen their geographical boundaries, technological developments and to innovate their drug productivity, Indian pharma companies prefer strategic partnership, joint ventures, and licensing agreements. This method not only facilitates knowledge transfer but also assists in the internationalization of a brand.
• Diversification of market: Indian pharma companies are moving beyond their traditional product range as they strive to enter into global markets to serve a wider customer base. Providing products as wide as generics, branded generics, specialty drugs, biosimilars and vaccines, the company can capture a substantial international market share that will eventually cover different conditions and needs.
• Government support: The government has issued some policies like tax incentives, export enhancing schemes and PLI schemes to foster the growth of Indian pharmaceutical companies. It launched a PLI scheme with an initial outlay of Rs. 15,000 crore (US$ 1.80 billion) until 2027-28. This in turn enhances the country's manufacturing abilities by encouraging investment and production.